Corporate
Palvella Soars 38% as QTORIN Phase 3 Trial Delivers First-Ever Treatment for Rare Lymphatic Disease
3d ago
You're signed outSign in or to get full access.
PALVELLA THERAPEUTICS (PVLA) Earnings Call Transcripts
Browse quarterly earnings call transcripts for PALVELLA THERAPEUTICS.